Delivery Order SPE2DR25D2104-SPE2DR26F3NRF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,208.14 to AmerisourceBergen Drug Corp for the supply of Movantik (naloxegol) 25 mg tablets in a quantity of 30 units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of October 29, 2025. The award was issued on October 28, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,415.93 by the Defense Logistics Agency on September 9, 2025, for the supply of Movantik 25 mg tablets (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 10, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a firm fixed price of $1,177.53 and a completion date of June 27, 2025. The contract is not set aside and was awarded on June 26, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $7,869.78 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 30 tablets of Movantik, a medication used to treat opioid-induced constipation, to an unspecified location in Conshohocken, Pennsylvania. The single-award delivery order was issued on September 12, 2023 under an existing Amerisourcebergen contract vehicle and has a period of performance through September...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $1,236.40. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by September 25, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.29 to AmerisourceBergen Drug Corp for the supply of Meloxicam 15 mg tablets in unit dose packaging (100s). This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on August 25, 2025, with an ultimate completion date of August 26, 2025. This contract, valued at $2,857.19, covers the delivery of Motegrity 2 mg tablets (30-count units) and represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NRFDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,254.76 for 30 tablets of Movantik 25 mg on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Movantik (naloxegol) is a prescription medication commonly used in pain management protocols, consistent with AmerisourceBergen's extensive portfolio of therapeutic medications distributed through the DLA Medical Supply Chain to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/7/25 |